Foot And Mouth Disease Vaccine Market Size, Share & Trends Analysis Report By Animal (Cattle, Sheep & Goat, Swine), By Vaccine (Modified/Attenuated Live), By Distribution Channel, By Region, And Segment Forecasts, 2024

Description

Foot And Mouth Disease Vaccine Market Growth & Trends:

The global foot and mouth disease vaccine market size is expected to reach USD 3.88 billion by 2030, registering a CAGR of 8.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increase in the incidence of FMD and their socioeconomic impact over international trade of animal products are propelling the demand for FMD vaccines. In addition, effectiveness for a lower time period propels the repeat purchase of vaccines.

This market is highly competitive and various government entities intervene for bulk purchase of vaccines. There has been dynamic growth in the global livestock population over the past few decades. In developing countries, the demand for livestock products is increasing owing to which concern for healthy livestock population is increasing. Rising demand for animal products has revolutionized the global livestock production. In addition, factors such as a change in food preferences owing to changing lifestyles coupled with a growing population are anticipated to boost the demand for livestock products.

Increased adoption of oil-based vaccines owing to their higher efficacy is expected to contribute to the largest share of conventional vaccines. Available conventional vaccines are effective in the prevention of clinical diseases; however, they offer protection for a shorter duration. Hence, as a prophylactic measure, frequent vaccination becomes necessary.

Foot And Mouth Disease Vaccine Market Report Highlights:

The inactivated (killed) vaccine segment dominated the market and accounted for a market share of 53.0% in 2023.
Cattle dominated the market with a market share of 53.5% in 2023 and is expected to grow at the fastest CAGR over the forecast period.
The swine segment is expected to grow at a significant CAGR over the forecast period. It is attributed to the rising demand for pork as it is a good source of protein and income source in many developing countries across the world.
Asia Pacific foot & mouth disease vaccine market dominated with a revenue share of 48.2% in 2023 owing to the growing livestock population and high prevalence of FMD in this region.

Product Code: GVR-1-68038-656-1

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Foot & Mouth Disease Vaccine Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Foot & Mouth Disease Vaccine Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Foot & Mouth Disease Vaccine Market: Animal Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Foot & Mouth Disease Vaccine Market: Animal Movement Analysis, 2023 & 2030 (USD Million)
4.3. Cattle
- 4.3.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Sheep and Goat
- 4.4.1. Sheep and Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Swine
- 4.5.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
- 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Foot & Mouth Disease Vaccine Market: Vaccine Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Foot & Mouth Disease Vaccine Market: Vaccine Movement Analysis, 2023 & 2030 (USD Million)
5.3. Modified/ Attenuated Live
- 5.3.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Inactivated (Killed)
- 5.4.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Other Vaccines (DNA vaccines, Peptide vaccines)
- 5.5.1. Other Vaccines (DNA vaccines, Peptide vaccines) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Foot & Mouth Disease Vaccine Market: Distribution Channel Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Foot & Mouth Disease Vaccine Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
6.3. Veterinary Hospitals & Clinics
- 6.3.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Government Institutions
- 6.4.1. Government Institutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
- 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Foot & Mouth Disease Vaccine Market: Regional Estimates & Trend Analysis

7.1. Foot & Mouth Disease Vaccine Market Share, By Region, 2023 & 2030 (USD Million)
7.2. Europe
- 7.2.1. Europe Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. Russia
  - 7.2.2.1. Russia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. France
  - 7.2.3.1. France Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Asia Pacific
- 7.3.1. Asia Pacific Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. Japan
  - 7.3.2.1. Japan Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. China
  - 7.3.3.1. China Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. India
  - 7.3.4.1. India Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. South Korea
  - 7.3.5.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Indonesia
  - 7.3.6.1. Indonesia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. South Korea
  - 7.3.7.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Thailand
  - 7.3.8.1. Thailand Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Latin America
- 7.4.1. Latin America Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Brazil
  - 7.4.2.1. Brazil Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Argentina
  - 7.4.3.1. Argentina Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Middle East and Africa
- 7.5.1. Middle East and Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. South Africa
  - 7.5.2.1. South Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Saudi Arabia
  - 7.5.3.1. Saudi Arabia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. UAE
  - 7.5.4.1. Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Kuwait
  - 7.5.5.1. Kuwait Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Egypt
  - 7.5.6.1. Egypt Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Turkey
  - 7.5.7.1. Turkey Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Merck & Co., Inc.
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Biogenesis Bago
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. Zoetis Inc.
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Boehringer Ingelheim International GmbH
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Indian Immunologicals Limited
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Bayer AG
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. Hester Biosciences Limited
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Brilliant Bio Pharma Limited
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/ Strategic Initiatives
- 8.4.10. Biovet Private Ltd
  - 8.4.10.1. Participant's Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Recent Developments/ Strategic Initiatives

Foot And Mouth Disease Vaccine Market Size, Share & Trends Analysis Report By Animal (Cattle, Sheep & Goat, Swine), By Vaccine (Modified/Attenuated Live), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030